STEP BY STEP GUIDE: CONSIDERATIONS FOR GETTING STARTED ON QOF
CONSIDER RESOURCE ALLOCATION AND REPORTING TIMELINES FOR QOF CHOL001 AND CHOL00
CASE STUDY EXAMPLE OF A PATIENT PATHWAY FOR LIPID MANAGEMENT IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
ESC/EAS GUIDELINES SUPPORT A LOWER IS BETTER APPROACH WITH COMBINATION THERAPY TO REDUCE CV RISK IN UNCONTROLLED PATIENTS
STATINS ARE RECOMMENDED AS FIRST LINE TREATMENT FOR PATIENTS WITH RAISED CHOLESTEROL BUT ARE OFTEN INSUFFICIENT TO ACHIEVE LIPID TARGETS
AROUND 70% OF HIGH-RISK ASCVD PATIENTS USING MODERATEOR HIGH-INTENSITY STATINS ARE NOT REACHING THE LDL-C TREATMENT GOAL OF < 1.8MMOL/L
BEMPEDOIC ACID AND BEMPEDOIC ACID+EZETIMIBE ARE AVAILABLE FOR USE IN PRIMARY CARE: THEY DO NOT REQUIRE INITIATION BY SPECIALIST SERVICES
MANAGE YOUR PATIENTS’ LIPIDS IN PRIMARY CARE WHERE POSSIBLE TO AVOID THE NEED FOR SECONDARY CARE REFERRAL
EMIS®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002
EMIS®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002
ARDENS® EXEMPLAR SEARCH WITHIN EMIS WEB®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002
SYSTMONE® END OF YEAR EXEMPLAR SEARCH: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002
SYSTMONE® HOW AM I DRIVING? EXEMPLAR SEARCH: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002
Comments